The initial dosages of Pfizer and BioNTech’s Covid-19 vaccines might head out next month, if the FDA grants emergency authorization. There are likewise 3 other appealing vaccine candidates in the pipeline from AstraZeneca, Moderna, and Johnson & Johnson. The process of dispersing the vaccine to the 330 million people living in the U.S., however, might prove a logistical challenge. Here’s a look at how the federal government plans to do it.
About CNBC: From ‘Wall Street’ to ‘Main Street’ to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special preview of your preferred shows, unique video and more.
Get In Touch With CNBC News Online.
Get the current news: https://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC
Subscribe to CNBC PRO: https://cnb.cx/2NLi9AN
How The U.S. Strategies To Disperse Covid-19 Vaccines.